971 filings
Page 4 of 49
4
John Michael Klopp
16 Mar 23
Acer Therapeutics / John Michael Klopp ownership change
4:43pm
4
Joseph Donald
16 Mar 23
Acer Therapeutics / Donald Joseph ownership change
4:41pm
4
Tanya Hayden
16 Mar 23
Acer Therapeutics / Tanya Hayden ownership change
4:39pm
4
Michelle Renee Griffin
16 Mar 23
Acer Therapeutics / MICHELLE RENEE GRIFFIN ownership change
4:37pm
4
ACER
Acer Therapeutics Inc.
16 Mar 23
Acer Therapeutics / JOHN MICHAEL DUNN ownership change
4:35pm
4
ACER
Acer Therapeutics Inc.
16 Mar 23
Acer Therapeutics / Jefferson E Davis ownership change
4:32pm
4
Steve Aselage
16 Mar 23
Acer Therapeutics / STEVE ASELAGE ownership change
4:30pm
4
Jason Amello
16 Mar 23
Acer Therapeutics / Jason Amello ownership change
4:21pm
8-K
ACER
Acer Therapeutics Inc.
15 Mar 23
Other Events
9:00am
SC 13G/A
Nantahala Capital Management, LLC
14 Feb 23
Acer Therapeutics / Nantahala Capital Management ownership change
4:56pm
8-K
ACER
Acer Therapeutics Inc.
13 Feb 23
Topline trial results expected mid-March 2023
9:00am
424B2
ACER
Acer Therapeutics Inc.
7 Feb 23
Prospectus for primary offering
4:08pm
8-K
ACER
Acer Therapeutics Inc.
7 Feb 23
Other Events
4:01pm
8-K
ACER
Acer Therapeutics Inc.
1 Feb 23
Regulation FD Disclosure
4:03pm
8-K
ACER
Acer Therapeutics Inc.
31 Jan 23
Entry into a Material Definitive Agreement
9:25am
8-K
ACER
Acer Therapeutics Inc.
9 Jan 23
Acer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones
9:00am
8-K
ACER
Acer Therapeutics Inc.
5 Jan 23
Regulation FD Disclosure
9:00am
8-K
ACER
Acer Therapeutics Inc.
3 Jan 23
Entry into a Material Definitive Agreement
9:00am
8-K
ACER
Acer Therapeutics Inc.
29 Dec 22
Other Events
9:00am
8-K
ACER
Acer Therapeutics Inc.
27 Dec 22
New FDA-approved formulation for patients living with urea cycle disorders
8:33am